Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Centurion Acquisition | ALFUU | Aug 30, 2024 | 10.06 | 0.00 |
Century Aluminium | CENX | Aug 30, 2024 | 14.36 | -0.97 |
Century Casinos | CNTY | Aug 30, 2024 | 2.46 | +0.41 |
Century Communities | CCS | Aug 30, 2024 | 100.07 | +0.64 |
Century Therapeutics | IPSC | Aug 30, 2024 | 1.76 | +1.73 |
Cepton | CPTN | Aug 30, 2024 | 3.05 | -0.26 |
Ceragon Networks | CRNT | Aug 30, 2024 | 2.98 | +3.47 |
Cerence | CRNC | Aug 30, 2024 | 3.30 | -4.62 |
Cerevel Therapeutics | CERE | Aug 30, 2024 | 44.96 | 0.00 |
CERo Therapeutics | CERO | Aug 30, 2024 | 0.13 | -2.00 |
Certara | CERT | Aug 30, 2024 | 12.25 | -0.33 |
Cerus | CERS | Aug 30, 2024 | 2.26 | -1.31 |
CervoMed | CRVO | Aug 30, 2024 | 18.62 | +12.71 |
Cetus Capital Acquisition | CETU | Aug 30, 2024 | 2.22 | 0.00 |
CEVA | CEVA | Aug 30, 2024 | 23.94 | -0.13 |
CF Acquisition VII A | CFFS | Aug 30, 2024 | 11.04 | 0.00 |
CF Bankshares | CFBK | Aug 30, 2024 | 21.75 | +1.97 |
CF Industries | CF | Aug 30, 2024 | 83.09 | +0.19 |
CFSB Bancorp | CFSB | Aug 30, 2024 | 6.56 | 0.00 |
CG Oncology | CGON | Aug 30, 2024 | 36.88 | +0.55 |
CGI | GIB | Aug 30, 2024 | 112.63 | +1.08 |
Chain Bridge I SPAC A | CBRG | Aug 30, 2024 | 11.25 | +0.63 |
Chain Bridge I Units | CBRGU | Aug 30, 2024 | 11.01 | 0.00 |
Champion Homes | SKY | Aug 30, 2024 | 93.41 | +2.43 |
Champions Oncology | CSBR | Aug 30, 2024 | 4.22 | +1.05 |
ChampionX | CHX | Aug 30, 2024 | 31.13 | -0.19 |
Chanson International | CHSN | Aug 30, 2024 | 1.63 | +0.93 |
ChargePoint | CHPT | Aug 30, 2024 | 1.88 | +1.08 |
Charles & Colvard | CTHR | Aug 30, 2024 | 1.52 | -4.10 |
Charles River Laboratories International | CRL | Aug 30, 2024 | 197.75 | -0.77 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.